GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of is it normal to get reflux at week 20 — 44 comments in the full submission. View in context.
4k
c/trialwatch·submitted 2 years ago by u/hugo_norgaard

is it normal to get reflux at week 20

Statsbranch of 6 comments

Quick one. Canada here. endpoint works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 9 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 44 comments →

This branch

6 comments, started 2 years ago
u/aurel_mwangi687 points·2 years ago

Which trial and what was the primary endpoint?

replysharereportpermalink
u/hub_opssite staff566 points·2 years ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/receptor_bias_rick381 points·2 years ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/nordic_pricing164 points·2 years ago

give the trial name, phase, n, and primary endpoint in the body

Disagree on that part. 98.7% and 99.3% on the same vial is normal.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →